Connor, Clark & Lunn Investment Management Ltd. Boston Scientific Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$26 Billion
Q2 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Boston Scientific Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 2,145 shares of BSX stock, worth $214,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,145

Previous 108,080 98.02%

Holding current value

$214,285

Previous $10.9 Million 97.89%

% of portfolio

0.0%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$89.7 - $107.41 $9.5 Million - $11.4 Million	-105,935 Reduced 98.02%	2,145 $230,000
Q1 2025 May 12, 2025	BUY	$89.38 - $106.18 $2.37 Million - $2.81 Million	26,489 Added 32.47%	108,080 $10.9 Million
Q4 2024 Feb 10, 2025	SELL	$83.62 - $91.5 $11.5 Million - $12.6 Million	-137,165 Reduced 62.7%	81,591 $7.29 Million
Q3 2024 Nov 08, 2024	BUY	$72.96 - $84.0 $14.3 Million - $16.4 Million	195,461 Added 839.07%	218,756 $18.3 Million
Q2 2024 Aug 09, 2024	BUY	$67.33 - $77.71 $785,337 - $906,409	11,664 Added 100.28%	23,295 $1.79 Million
Q1 2024 May 09, 2024	SELL	$57.6 - $68.62 $4.22 Million - $5.03 Million	-73,281 Reduced 86.3%	11,631 $796,000
Q4 2023 Feb 09, 2024	BUY	$48.64 - $57.81 $4.13 Million - $4.91 Million	84,912 New	84,912 $4.91 Million
Q3 2022 Nov 10, 2022	SELL	$36.71 - $109.66 $101,723 - $303,867	-2,771 Reduced 1.65%	165,073 $6.39 Million
Q2 2022 Aug 05, 2022	SELL	$35.24 - $47.1 $4.45 Million - $5.94 Million	-126,207 Reduced 42.92%	167,844 $6.26 Million
Q1 2022 May 12, 2022	BUY	$40.9 - $45.1 $12 Million - $13.3 Million	294,051 New	294,051 $13 Million
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $3.91 Million - $4.35 Million	-94,751 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$38.58 - $44.24 $5.11 Million - $5.86 Million	-132,553 Reduced 58.32%	94,751 $4.05 Million
Q1 2021 May 13, 2021	BUY	$35.27 - $39.67 $8.02 Million - $9.02 Million	227,304 New	227,304 $8.79 Million
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $6.3 Million - $7.98 Million	-190,152 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $5.4 Million - $6.62 Million	156,839 Added 470.8%	190,152 $7.27 Million
Q4 2019 Feb 12, 2020	BUY	$37.87 - $45.37 $1.26 Million - $1.51 Million	33,313 New	33,313 $1.51 Million
Q2 2019 Aug 07, 2019	SELL	$34.91 - $42.98 $272,751 - $335,802	-7,813 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$32.91 - $40.75 $257,125 - $318,379	7,813 New	7,813 $300,000
Q1 2018 May 14, 2018	SELL	$25.2 - $28.54 $6.94 Million - $7.86 Million	-275,339 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$24.79 - $29.8 $4.88 Million - $5.86 Million	-196,775 Reduced 41.68%	275,339 $6.83 Million
Q3 2017 Nov 14, 2017	SELL	$26.26 - $29.17 $10 Million - $11.1 Million	-380,900 Reduced 44.65%	472,114 $13.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	853,014	853,014 $23.6 Million

Others Institutions Holding BSX

# of Institutions

1,920

Shares Held

1.26B

Call Options Held

9.59M

Put Options Held

7.17M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $143B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Boston Scientific Corp Transaction History